Eubel Brady & Suttman Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$223K Hold
242
0.03% 108
2025
Q4
$260K Buy
+242
New +$231K 0.03% 106
2024
Q3
Sell
-255
Closed -$231K 95
2024
Q2
$231K Buy
+255
New +$204K 0.03% 87
2016
Q1
Sell
-3,497
Closed -$295K 79
2015
Q4
$295K Hold
3,497
0.1% 65
2015
Q3
$293K Hold
3,497
0.1% 61
2015
Q2
$292K Sell
3,497
-764
-18% -$58.2K 0.1% 63
2015
Q1
$310K Hold
4,261
0.09% 61
2014
Q4
$294K Buy
4,261
+411
+11% +$27.7K 0.09% 61
2014
Q3
$250K Buy
3,850
+130
+3% +$8.23K 0.07% 72
2014
Q2
$231K Buy
+3,720
New +$222K 0.07% 73

Other funds holding LLY

Eubel Brady & Suttman Asset Management's LLY Position: Q1 2026 in Review

Eubel Brady & Suttman Asset Management held its Eli Lilly (LLY) position steady in Q1 2026 at 242 shares worth $223K. The position accounts for 0.03% of the portfolio, ranked #108.

Eubel Brady & Suttman Asset Management first reported a position in LLY in Q2 2014 and has held it in 10 quarters since. The position peaked at $310K in Q1 2015. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Eubel Brady & Suttman Asset Management held 242 shares of Eli Lilly worth $223K as of Q1 2026.
  • Eubel Brady & Suttman Asset Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.03% of Eubel Brady & Suttman Asset Management's portfolio in Q1 2026, its #108 holding.
  • Eubel Brady & Suttman Asset Management first reported a position in Eli Lilly in Q2 2014 and has held it in 10 quarters since.
  • Eubel Brady & Suttman Asset Management's Eli Lilly position peaked at $310K in Q1 2015.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q1 2026, filed 11 May 2026.